Articles From: BioScrip Appoints Thomas Pettit As Senior Vice President And Chief Operating Officer to Birds Eye® Vegetables and Disney® Team Up to Launch Veggin’ In LA with Laura Marano Sweepstakes


ELMSFORD, N.Y. , July 18, 2014 /PRNewswire/ -- BioScrip, Inc. (NASDAQ: BIOS) (the "Company") today announced that Thomas F.
Sign-up for BioScrip Appoints Thomas Pettit As Senior Vice President And Chief Operating Officer investment picks
ELMSFORD, N.Y. , Aug.
Sign-up for BioScrip Reports Second Quarter 2014 Financial Results investment picks
ELMSFORD, N.Y. , July 23, 2014 /PRNewswire/ -- BioScrip ® , Inc. (NASDAQ: BIOS) announced today that the Company will release its 2014 second quarter financial results on Wednesday, August 6, 2014 , after the market closes.
Sign-up for BioScrip To Host Second Quarter 2014 Earnings Call investment picks
2014/8/6
SINGAPORE , Aug.
Sign-up for Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015 investment picks
ADVISORY, July 22, 2014 (GLOBE NEWSWIRE) -- What: BioSpecifics Technologies Corp (Nasdaq:BSTC) , a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date, will visit the NASDAQ MarketSite in Times Square.
Sign-up for BioSpecifics Technologies Corp (NASDAQ: BSTC) to Ring the NASDAQ Stock Market Opening Bell investment picks
LYNBROOK, N.Y. , June 25, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
Sign-up for BioSpecifics Technologies Corp. Announces Filing by Sobi for EU Approval of XIAPEX for Peyronies Disease investment picks
LYNBROOK, N.Y. , Sept.
Sign-up for BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences investment picks
LYNBROOK, N.Y. , Aug.
Sign-up for BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results investment picks
LYNBROOK, N.Y. , June 27, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
Sign-up for BioSpecifics Technologies Corp. to Be Added to Russell 3000® Index investment picks
-- Revenue increased by 31% to $19.2 million --
Sign-up for Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results investment picks
Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Biota Pharmaceuticals, Inc, (Nasdaq: BOTA) violated state or federal laws.
Sign-up for BIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Biota Pharmaceuticals, Inc. investment picks
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced that Boris Peaker has joined Cowen and Company’s Equity Research department as a Managing Director to cover Biotechnology stocks.
Sign-up for Biotechnology Analyst Boris Peaker Joins Cowen’s Equity Research Department investment picks
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced that Ritu Baral has joined Cowen and Company’s Equity Research department as a Managing Director to cover Biotechnology stocks.
Sign-up for Biotechnology Analyst Ritu Baral Joins Cowen’s Equity Research Department investment picks
MALVERN, Pa., July 31, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT) , the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2014.
Sign-up for BioTelemetry, Inc. Reports Second Quarter 2014 Financial Results investment picks
MALVERN, Pa., July 22, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT) will release its second quarter 2014 earnings on Thursday, July 31, 2014 at 4:00 PM Eastern Time.
Sign-up for BioTelemetry, Inc. to Release Second Quarter 2014 Earnings Results on July 31, 2014 investment picks
BioTime, Inc. (NYSE MKT:BTX) announced that its subsidiary Asterias Biotherapeutics, Inc. (OTCBB:ASTY) has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1/2a clinical trial of its product, AST-OPC1, in patients with complete cervical spinal cord injury.
Sign-up for BioTime Subsidiary Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients With Cervical Complete Spinal Cord Injury investment picks
BioTime, Inc. (NYSE MKT: BTX) announced that its subsidiary Asterias Biotherapeutics, Inc. (OTCBB: ASTY) has reached an agreement with Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialization arm, to conduct a clinical trial of Asterias’ novel immunotherapy treatment AST-VAC2 in subjects with non-small cell lung cancer.
Sign-up for BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology Partner for Clinical Trial of Immunotherapy Vaccine for Lung Cancer investment picks
2014/8/6
Bird Construction Inc. Announces Strong 2014 Second Quarter Financial Results Canada NewsWire LISTING: TORONTO STOCK EXCHANGE SYMBOL: BDT MISSISSAUGA, ON , Aug.
Sign-up for Bird Construction Inc. Announces Strong 2014 Second Quarter Financial Results investment picks
2014/8/28
Bird Construction Inc. Announces the Planned Retirement of Tim Talbott and the Appointment of Ian Boyd as President & CEO Canada NewsWire LISTING: TORONTO STOCK EXCHANGE SYMBOL: BDT TORONTO , Aug.
Sign-up for Bird Construction Inc. Announces the Planned Retirement of Tim Talbott and the Appointment of Ian Boyd as President & CEO investment picks
2014/8/18
Birds Eye ® frozen vegetables and the Walt Disney Company ® are teaming up to increase vegetable consumption among children in the United States.
Sign-up for Birds Eye® Vegetables and Disney® Team Up to Launch Veggin’ In LA with Laura Marano Sweepstakes investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: BioScrip Appoints Thomas Pettit As Senior Vice President And Chief Operating Officer to Birds Eye® Vegetables and Disney® Team Up to Launch Veggin’ In LA with Laura Marano Sweepstakes
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices